ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer.
JianYu YangYu XuYanMiao HuoLi CaiRong HuaJun-Feng ZhangZhong ChenPublished in: Journal of immunology research (2021)
Our findings uncover ERO1L contributes to hepatic metastasis in PDAC via epithelial-mesenchymal transition (EMT) process and indicate a promising therapeutic strategy for PDAC hepatic metastasis.